Location: Nigeria and United States
54gene is working to understand more about African genomics concerning both non-communicable diseases and infectious diseases.
A lack of background diversity in healthcare research and information is a known issue where there has been slow progress. In pharmaceutical research, close to 90% of genetic material used is caucasian, and only 2% is African. This lack of racial diversity in research hinders the advancements in healthcare that benefits everyone.
By focusing on African genomics research, 54gene aims to close the gap, which could power medical breakthroughs. Their 54gene Biobank™, a biorepository located in Nigeria, houses biological samples for use in both development and academic research. Ethical standards are followed, and anonymised patient data is used.
54gene is focused on genomic studies in both infectious diseases and non-communicable diseases (NCDs). Very little is known about the genetic basis of NCDs in Africa despite their frequency. 54gene is currently studying cardiovascular disease, sickle cell, endocrine disorders, cancer, and neurodegenerative diseases.